Loading insider details...
Latest Form 4 (Jul 25, 2026): Grant/Award of 2,312,138 RXST shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 25, 2026 | RxSight, Inc. (RXST) | Grant/Award | 2,312,138 | n/a |
| Mar 19, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 4,286 | $297.5K |
| Mar 17, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 26,482 | n/a |
| Mar 9, 2026 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 30,724 | n/a |
| Jun 11, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 17,500 | $765.8K |
| Mar 21, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Sale | 3,643 | $168.6K |
| Mar 19, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 20,957 | n/a |
| Mar 7, 2025 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 33,691 | n/a |
| Mar 19, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Exercise/Conversion | 12,938 | n/a |
| Mar 11, 2024 | Tarsus Pharmaceuticals, Inc. (TARS) | Grant/Award | 47,500 | n/a |